Sponsored by Ultragenyx Pharmaceutical Inc.
| Variant ID | 233 |
|---|---|
| Genomic Coordinate (GRCh38) | g.22094005T>C |
| Variant | c.755T>C |
| Variant Start Position | 755 |
| Location | Exon 7 |
| Amino Acid Change | p.Phe252Ser |
| ACMG Call | - |
| ACMG Call Last Revised Date | 4/28/2021 |
| Predicted ACMG Call | Likely Pathogenic | Effect Type | Missense |
| Variant Type | SNV |
| PMID | 9106524, 16636593, 11502829, 34806794 |
| Article Count | 4 |
| Times Observed | < 3 |
| Clinical Phenotype | - |
| ACMG Categories | pm2, pp3, ppc |
| ACMG Explanations | pm2: chrX:22112123 ref:T alt:C was not found in gnomAD exomes or genomes. pp3: The SIFT, MutationTaster, and PolyPhen predictions agree that this variant is possibly or probably damaging. |
| Variant in Clinvar | Yes |
| ClinVar Classification | Uncertain/conflicting |
| Categories In Literature | ppc |
| No Contrary Evidence Found | Yes |
| ExAC Allele Frequency | - |
| Thousand Genomes Allel Frequency | - |
| Ontology Relations | - |
| hg19 Mapping Failed | No |
| Literature Alleles | X-22112123-T-C |
| GnomAD Alleles | - |
| DBNSFP Alleles | X-22112123-T-C |
| Other Alleles | X-22112122-TTC-AGT X-22112122-TT-AG X-22112123-TC-CT X-22112123-TC-CG X-22112123-TC-CA |
| Note | nan |
| Warnings | - |